raddar to Become a Mass-Media Platform with National Scale and Local Precision 
Dynabook Portégé Z40L-N: The No-Dongle Travel Companion Your Staff (And You!) Actually Need Kane Biotech to Release Second Quarter 2021 Financial Results on August 26 – Conference Call to Follow
WINNIPEG, Manitoba, Aug. 19, 2021 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…
Covis Pharma Announces FDA’s Decision to Grant Public Hearing for Only FDA-Approved Treatment to Reduce Preterm Birth in Indicated Patients
ZUG, Switzerland, Aug. 19, 2021 (GLOBE NEWSWIRE) — Covis Group S.à r.l. (“Covis”) announced today that…
AB Science announced the publication of a pathogenic mechanism triggered by mast cells in the amyotrophic lateral sclerosis (ALS) spinal cord that can be targeted by masitinib
PRESS RELEASE NEW DATA REVEAL THE DELETERIOUS ROLE OF ACTIVATED MAST CELLS ON MOTOR NEURONS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND THE…
Avicanna Announces Closing of Secured Debt Financing
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs
Nicosia, Cyprus, Aug. 19, 2021 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and one of…
22nd Century Group Appoints Accomplished Life Sciences and Biotechnology Executive Anthony Johnson to Board of Directors
Anthony Johnson Anthony Johnson – Board of Directors Visionary in the Fields of Biotechnology and Genomics…
Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary Announces Expansion of Ztlido® Managed Care Coverage for Additional 33 Million Lives
PALO ALTO, Calif., Aug. 19, 2021 (GLOBE NEWSWIRE) — Scilex Holding Company (SCILEX), a subsidiary…
Heat Biologics Announces New Additions to Biothreat Advisory Board
Former Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs, Andrew C. Weber Expert…
Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome
Company announcement – No. 52 / 2021 Zealand Pharma Announces First Patient Dosed in EASE-SBS…
Ensysce Biosciences to Host Satellite Symposium with Dr. Jeffrey Gudin at PAINWeek 2021 on September 9, 2021
SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
Humacyte Highlights Robust Expanded Access Program and Patient Testimonial for Human Acellular Vessels
On October 5th, 2020, Devin Barnett was critically injured by a crane while working at…
Otonomy Appoints Jill Broadfoot to Board of Directors
SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated…
Adamis Highlights National Institutes of Health (NIH) Article Entitled, “Tempol: A Potential Home Treatment for COVID-19”
NIH Researchers Contend that Tempol can be taken orally and may stop the replication of…
Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)
Collaboration to evaluate NEObody™ product candidate, ADG106, in combination with KEYTRUDA® for patients with advanced…
Silo Wellness Announces $3 Million U.S. Sales and Distribution Partnership for Marley One Line of Functional Mushrooms
TORONTO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness” or the “Company”)…
Plus Therapeutics Presents Data from Preclinical Study of Rhenium-186 Nanoliposome in Leptomeningeal Metastases and Plans for Further Evaluation with Upcoming Phase 1 Clinical Trial
Positive data to support FDA IND application for the clinical evaluation of Rhenium-186 Nanoliposome (186RNL)…
Larimar Therapeutics Announces Upcoming Oral Presentation at the World Orphan Drug Congress
BALA CYNWYD, Pa., Aug. 19, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
Alladapt Initiates Buildout of New Manufacturing Facility for Production of Novel, Investigational Oral Immunotherapeutic Designed to Address a Broad Range of Food Allergies
ADP101 is a singular optimized, pharmaceutical-grade oral immunotherapy candidate currently in a Phase 1/2 clinical…
MediPharm Labs Australia Receives Government Grant to Assist with International Expansion
Received first instalment of a government grant for $330,000AUD as part of the Australian government’s…
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
Debuted as Publicly Traded Company and Raised $100 Million in Gross Proceeds to Fund Liquid…